Join
Live feed
·
INSIDERFilingvia Quantisnow
Collegium Pharmaceutical Inc. logo

EVP and General Counsel Kuhlmann Shirley R. sold $773,792 worth of shares (20,225 units at $38.26), decreasing direct ownership by 15% to 119,184 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COLL (Collegium Pharmaceutical Inc.) and more on Quantisnow.